Trial no.:
|
PACTR201411000933365 |
Date of Approval:
|
08/11/2014 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Antagonist versus agonist protocols: in patients with polycystic ovary syndrome treated for ICSI cycles |
Official scientific title |
Fixed gonadotrophin releasing hormone antagonist protocol versus gonadotrophin releasing hormone agonist : long protocol in patients with polycystic ovary syndrome treated for ICSI cycles. |
Brief summary describing the background
and objectives of the trial
|
Cases divided into 2 groups 100 cases take agonist(Decapeptyl) 0.1mg 6 days before discontinuation of ocps .100 cases will take antagonist (Cetrotide). 0.25mg in cycle day5.Gonadotrophin taken when desensitization occur in agonist group , taken in day 3 in antagonist group.Both agonist and antagonist continued till the day of hCG.hCG taken when follicles reach adiameter of ¿ 18mm in agonist group and ¿ 17mm in antagonistbgroup.The aim is to compare between both protocols in PCOS patients undergoing ICSI and ICSI outcome.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Infertility in PCOS patients,Obstetrics and Gynecology |
Sub-Disease(s) or condition(s) being studied |
Fertility-female |
Purpose of the trial |
Treatment: Other |
Anticipated trial start date |
01/06/2014 |
Actual trial start date |
01/06/2014 |
Anticipated date of last follow up |
31/12/2014 |
Actual Last follow-up date |
31/12/2014 |
Anticipated target sample size (number of participants) |
200 |
Actual target sample size (number of participants) |
200 |
Recruitment status |
Closed to recruitment,follow-up continuing |
Publication URL |
|
|